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are deemed to be synonymous for the purposes of the provisions of law regarding
the Ii censure and regulation of optometry.
[S. B&PJ

SB 921 (Maddy), as introduced March
4, would provide that it is unprofessional
conduct for an optometrist to fail to advise
a patient in writing of any pathology that
requires the attention of a physician when
an examination of the eyes indicates a
substantial likelihood of any pathology.
[S. B&PJ

SB 842 (Presley), as amended April
13, would authorize the Board to issue
interim orders of suspension and other
license restrictions, as specified, against
its licensees. [A. CPGE&EDJ

■ LITIGATION
In California Optometric Association
(COA) v. Division of Allied Health Professions, Medical Board of California,
No. 531542 (filed January 11 in Sacramento County Superior Court), and Engineers and Scientists of California (ESC),
et al. v. Division of Allied Health Professions, Medical Board of California, No.
706751-0 (filed October 8, 1992 in Alameda County Superior Court), COA and
ESC challenge the validity of DAHP's
medical assistant regulations.
Following the enactment of SB 645
(Royce) (Chapter 666, Statutes of 1988),
it took DAHP over three years to adopt
section 1366, Title 16 of the CCR, its
regulation defining the technical support
services which unlicensed medical assistants (MAs) may perform and establishing
standards for appropriate MA training and
supervision. During the lengthy rulemaking process, DCA rejected DAHP's proposed regulations twice and the Office of
Administrative Law rejected them once
before finally approving them in March
1992.
During the rulemaking hearings, COA
and the Board of Optometry objected to
language in the proposed regulations stating that MAs are permitted to perform
"automated visual field testing, tonometry, or other simple or automated ophthalmic testing not requiring interpretation in
order to obtain test results, using machines
or instruments, but are precluded from the
exercise of any judgment or interpretation
of the data obtained on the part of the
operator." [ 12: 1 CRLR 88-89J However,
DAHP overruled the objections and included this language in its final regulations. COA and ESC claim that section
1366 is invalid because the conduct authorized is beyond the scope of DAHP's
authority and conflicts with DAHP's enabling statutes; further, it conflicts with
Business and Professions Code sections
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3040 and 3041 (which define the practice
of optometry and prohibit unlicensed persons from engaging in optometry). At this
writing, the Attorney General has filed an
answer on behalf of DAHP; no court hearing has been set.

■ RECENT MEETINGS
At the February 18 meeting, Executive
Officer Karen Ollinger reviewed previously-approved budget changes, and reported that the Board is close to covering
its costs. Ollinger also announced that the
occupational analysis by Human Resource
Strategies is proceeding on schedule.
[ 13: 1 CRLR 59J Finally, Board President
Thomas Nagy, OD, announced that Board
member Stephen R. Chun, OD, was
named Optometrist of the Year at the annual California Optometric Association
Congress.

■ FUTURE MEETINGS
November 17-18 in Orange County.

BOARD OF PHARMACY
Executive Officer: Patricia Harris
(916) 445-5014
ursuant to Business and Professions
PCode
section 4000 et seq., the Board
of Pharmacy grants licenses and permits
to pharmacists, pharmacies, drug manufacturers, wholesalers and sellers of hypodermic needles. It regulates all sales of
dangerous drugs, controlled substances
and poisons. The Board is authorized to
adopt regulations, which are codified in
Division 17, Title 16 of the California
Code of Regulations (CCR). To enforce its
regulations, the Board employs full-time
inspectors who investigate accusations
and complaints received by the Board.
Investigations may be conducted openly
or covertly as the situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized by
law to suspend or revoke licenses or permits for a variety of reasons, including
professional misconduct and any acts substantially related to the practice of pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are appointed for four-year terms.

■ MAJOR PROJECTS
Restructuring the Enforcement
Unit. As the Board has not augmented its

enforcement program in at least ten years,
it spent considerable time at its October
1992 meeting discussing the need to expand the program in light of the increasing
number of pharmacies and licensed pharmacists in California, the establishment of
new registration programs such as medical device retailers and pharmacy technicians, and changes in the law governing
the practice of pharmacy. [ 13: 1 CRLR 60]
At the Board's April 28-29 meeting,
Executive Officer Patricia Harris reported
that the Governor and the budget subcommittees in both houses of the legislature
have tentatively approved a $703,000 increase to the Board's 1993-94 budget to
establish eight additional enforcement
unit positions: five inspectors, one supervising inspector, one consumer services
representative, and one office technician.
The increase in staff will enable the Board
to establish a public assistance unit staffed
by complaint handlers to assist consumers
who call with questions regarding pharmacy services and pharmacists; complaints would be opened by this unit and
referred to the inspection staff for investigation. This process is expected to enable
Board inspectors to focus their efforts on
inspection, not compiaint processing.
Harris cautioned that the full legislature
has yet to pass the Governor's budget, and
that the budget augmentation may be revised or deleted.
Board Discusses Request for Regulatory Change. At its January 20-21
meeting, the Board noted that it had received several requests to revise section
1719(c), Title 16 of the CCR, which provides that, as of April 16, 1992, all candidates for the pharmacist licensure examination who are graduates of a foreign
pharmacy school (any school located outside the United States) must demonstrate
proficiency in English by achieving a
score of at least 220 on the Test of Spoken
English administered by the Educational
Testing Service. Board member Gilbert
Castillo noted that the issue was originally
discussed by the Board and referred to its
Competency Committee for evaluation;
the Committee held preliminary hearings
and invited public input. Following discussion, the Board unanimously agreed
that it is in the best interest of the consumer to continue to require that foreign
pharmacy graduates pass the Test of Spoken English.
Board Considers Electronic Transmission of Prescriptions. At the Board's
January 20-21 meeting, the Board's Committee on Electronic Transmission and
Faxing of Prescriptions recommended
that the Board pursue statutory and regulatory changes to allow for the electronic
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transmission of prescriptions. Under the
Committee's proposal, the term "electronic transmission prescription" would
include both electronic image transmission prescriptions (any prescription order
for which a facsimile of the order is received by a pharmacy from a licensed
prescriber) and electronic data transmission prescriptions (any prescription order,
other than an electronic image transmission prescription, which is electronically
transmitted from a licensed prescriber to a
pharmacy). Under the proposal, if a prescription is electronically transmitted to a
pharmacy, the pharmacy must maintain a
hard copy. Following discussion, the Board
unanimously agreed to pursue statutory and
regulatory changes to allow for the electronic transmission of prescriptions; the proposal was subsequently included in the Department of Consumer Affairs' omnibus bill,
AB 1807 (Bronshvag) (see LEGISLATION).

Board Considers New Rulemaking
Proposals. At its January 20-21 and April
28-29 meetings, the Board discussed a
proposal to amend section 1732.3, Title 16
of the CCR, regarding continuing education (CE) courses. Among other things,
section 1732.3 currently provides that a
recognized CE provider's coursework
shall be valid for two years following the
initial Board approval; the Board is considering amending this section to provide
that such coursework would be valid for
up to three years following Board approval. This modification was suggested
by the Board's Continuing Education
Committee in recognition of the American
Council on Pharmaceutical Education's
policy allowing its approved CE providers
to use an expiration date of three years for
some courses. The Board is expected to
pursue this regulatory change; at this writing, however, the Board has not published
notice of its intent to do so in the California Regulatory Notice Register.
At its April 28-29 meeting, the Board
discussed the possibility of amending section 1717(a), Title 16 of the CCR, which
specifies that no medication shall be dispensed on prescription except in a new container which conforms with standards established in the official compendia; section
1717(a) provides for an exception to the rule
and designates one type of prescription container which may be reused under specific
conditions, including the condition that the
container be used for the same drug for the
same patient. The Board is expected to pursue an amendment to section 1717(a) to
include an additional type of prescription
container which may be reused under specific circumstances; at this writing, however,
the Board has not published notice of its

intent to do so in the California Regulatory
Notice Register.
Rulemaking Update. The following
is a status update on rulemaking proposals
discussed in detail in previous issues of
the Reporter.
• Compounding for Prescriber Office
Use. The Board's adoption of new sections 1716.1 and 1716.2, Title 16 of the
CCR, defines the quantity of compounded
medication which a pharmacist may provide to a prescriber for office use, and
specifies the minimum types of records
that pharmacies must keep when they furnish compounded medication to prescribers in quantities larger than required for
the prescriber's immediate office use or
when a pharmacy compounds medication
for future furnishing. [ 13: 1 CRLR 61 J
The Office of Administrative Law
(OAL) originally disapproved this regulatory action in June 1992 on the basis that
it failed to meet the clarity and necessity
standards of the Administrative Procedure
Act. The Board amended its proposal at its
October 1992 meeting to resolve OAL's
concerns, and released the modified language for a fifteen-day public comment
period in December. The Board then resubmitted the proposal to OAL, which
approved the action on April 7.
• Medical Device Retailers' Locked
Storage Requirements. On January 19,
OAL approved the Board's adoption of
new section 1748.2, Title 16 of the CCR,
which provides that a medical device retailer (MDR) may leave a dangerous device in a retail area of the MDR premises
during an absence of an exemptee if the
item is of sufficient size and weight that
removal from the premises would be difficult. Any dangerous devices designated
for display under section 1748.2 shall be
specifically listed in the written policies
and procedures of the MDR. [ 13: 1 CRLR
62]
However, OAL disapproved th!;!
Board's proposed adoption of section
. 17 48.1, Title 16 of the CCR, also regarding MDR locked storage; among other
things, the original version of section
1748.1 would have provided that dangerous devices shall be furnished from locked
storage only upon the oral or written authorization of an exemptee to an employee
of the MDR who operates the service vehicle. OAL found that the Board Jacked
statutory authority to allow a non-licensed
person to dispense dangerous devices at
the direction of an exemptee in this manner. The Board subsequently modified the
language, released it for a fifteen-day public comment period, and resubmitted it to
OAL; among other things, the modified
version provides that dangerous devices
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shall be furnished from locked storage
only by an exemptee. OAL approved the
Board's adoption of section 1748.l on
May 12.

• Patient Consultation Regulatwns.
On March 3, OAL approved the Board's
amendments to sections 1707. l and
1707 .2, and its adoption of new section
1707 .3, Title 16 of the CCR, which revise
the Board's patient consultation requirements to comply with federal Omnibus
Budget Reconciliation Act of 1990
(OBRA 90) standards. [13:1 CRLR 61]
However, at its April meeting, the
Board discussed further amendments to
section 1707.2. Subsection (a) of section
1707 .2 requires a pharmacist to provide
oral consultation to a patient or his/her
agent, upon request or whenever the pharmacist deems it warranted. Under subsection (b), a pharmacist must provide oral
consultation whenever the prescription
drug has not previously been dispensed to
a patient, and whenever a prescription
drug not previously dispensed to a patient
in the same dosage, form, strength, or with
the same written directions is dispensed
by the pharmacy. Subsection (e) states
that, notwithstanding the requirements in
(a) and (b), that a pharmacist is not required to provide oral consultation when
a patient or the patient's agent refuses such
consultation. According to the Department of Health Services (DHS), the
Board's current regulations may not be in
compliance with OBRA 90, which apparently requires pharmacists to offer an oral
consultation-an element which the
Board's regulations lack. Following discussion, the Board unanimously agreed to
leave its consultation regulations as they
are, and to seek clarification from DHS
and the Health Care Finance Administration (HCFA) on this issue.

■ LEGISLATION
AB 260 (W. Brown), as amended
April 12, and SB 1048 (Watson), as introduced March 5, would each establish the
Clean Needle and Syringe Exchange Pilot
Project, and would authorize pharmacists,
physicians, and certain other persons to
furnish hypodermic needles and syringes
without a prescription or permit as prescribed through the pilot project. [A.
Floor; S. H&HS]
AB 667 (Boland). The Pharmacy Law
regulates the use, sale, and furnishing of
dangerous drugs and devices, as defined;
the law prohibits a person from furnishing
any dangerous device, except upon the
prescription of a physician, dentist, podiatrist, or veterinarian. However, existing
Jaw provides that this prohibition does not
apply to the furnishing of any dangerous
101
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device by a manufacturer, wholesaler, or
pharmacy to each other or to a physician,
dentist, podiatrist, veterinarian, or physical therapist acting within the scope of
his/her license under sales and purchase
records that correctly give the date, the
names and addresses of the supplier and
the buyer, the device, and its quantity. As
amended March 29, this bill would provide that the prohibition also does not
apply to the furnishing of any dangerous
device by a manufacturer, wholesaler, or
pharmacy to a chiropractor acting within
the scope of his/her license.
Existing law authorizes a medical device retailer to dispense, furnish, transfer,
or sell a dangerous device only to another
medical device retailer, a pharmacy, a licensed physician, a licensed health care
facility, a licensed physical therapist, or a
patient or his/her personal representative.
This bill would additionally authorize a
medical device retailer to dispense, furnish, transfer, or sell a dangerous device
to a licensed chiropractor. [A. Health]
SB 849 (Bergeson). Under the Pharmacy Law, a "hospital pharmacy" means
and includes a pharmacy licensed by the
Board of Pharmacy and located within any
hospital, institution, or establishment that
maintains and operates organized inpatient facilities for the diagnosis, care, and
treatment of human illnesses in accordance with certain requirements. As
amended April 26, this bill would instead
define a "hospital pharmacy" to mean a
pharmacy licensed by the Board and located within a general acute care hospital,
as defined, acute psychiatric hospital, as
defined, or a special hospital, as defined
in accordance with certain requirements.
[S. B&PJ
SB 842 (Presley), as amended April
13, would permit the Board to issue interim orders of suspension and other license restrictions, as specified, against its
licensees. [A. CPGE&EDJ
AB 1807 (Bronshvag), as amended
May 3, would require a pharmacy, except
a nonresident pharmacy, that ships or
mails prescriptions to residents of California to provide certain toll-free telephone
service, and written notification of the
availability of that service to patients.
Existing law defines the term "prescription" for the purposes of existing law
relating to licensure of pharmacists, regulation of pharmacies, and regulation of
controlled substances. This bill would revise the definition, for these purposes, to
include electronically transmitted prescriptions, as defined.
Under existing law, it is a misdemeanor for any person to falsely represent
himself/herself to be a person who can
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lawfully prescribe a drug, or to falsely
represent that he/she is acting on behalf of
a person who can lawfully prescribe a
drug, in a telephone communication with
a registered pharmacist. This bill would
also make it a misdemeanor to make these
false representations by electronic communication. [A. W&MJ
AB 2099 (Epple). The Pharmacy Law
prohibits a pharmacist from dispensing
any prescription except in a container correctly labeled with certain types of information. As amended April 28, this bill
would additionally require the container
label to identify the condition for which
the drug was prescribed if the patient requests it and the prescription identifies the
condition. [A. W&MJ
AB 2155 (Polanco). Existing law requires prescription blanks in triplicate to
be issued by the Department of Justice and
furnished to any practitioner authorized to
write a prescription for Schedule II controlled substances. Existing law prohibits
the Department of Justice from issuing
more than l 00 triplicate prescription
blanks to any authorized practitioner. As
introduced March 5, this bill would establish the Medical and Pharmacy Ad Hoc
Committee within the Department of Consumer Affairs, and require it to study all
matters regarding the Department of
Justice's ongoing monitoring and oversight activities of prescriptions for Schedule II controlled substances and advise the
Attorney General on these matters. It
would require the Committee membership
to consist of a pharmacist and various
persons who are engaged in prescribed
specialties of medical practice. [A. W&MJ
SB 432 (Greene). Existing law generally
requires every prescription for a controlled
substance classified in Schedule II to be in
writing. One exception to this general requirement is when failure to issue a prescription for a controlled substance classified in
Schedule II to a patient in a licensed skilled
nursing facility, an intermediate care facility,
or a licensed home health agency providing
hospice care would, in the opinion of the
prescriber, present an immediate hazard to
the patient's health and welfare or result in
intense pain and suffering to the patient;
under the circumstances, the prescription
may be dispensed upon an oral prescription.
As amended May 19, this bill would instead
provide that any order for a Schedule II
controlled substance in a licensed skilled
nursing facility, intermediate health care facility, or a licensed home health agency providing hospice care may be dispensed upon
an oral prescription. [S. Jud]
SB 1051 (McCorquodale). The Pharmacy Law requires a pharmacist to inform
a patient orally or in writing of the harmful

effects of a drug dispensed by prescription ,
if the drug poses a substantial risk to the
person consuming the drug when taken in
combination with alcohol or if the drug
may impair a person's ability to drive a
motor vehicle, whichever is applicable,
and the Board determines that the drug
requires the warning. The Pharmacy Law
requires any pharmacy located outside
California that ships, mails, or delivers
any controlled substances or dangerous
drugs or devices into this state pursuant to
a prescription to register with the Board,
disclose information regarding the pharmacy to the Board, and meet other conditions. Under the Pharmacy Law, one of
those conditions is the requirement that
the pharmacy, within a prescribed time
period, provide toll-free telephone service
to facilitate communication between patients in California and a pharmacist at the
pharmacy who has access to the patient's
records. It also requires the toll-free number to be disclosed on a label affixed to
each container of drugs dispensed to patients in this state. As amended April 21,
this bill would require the Board to adopt
regulations that apply the same requirements or standards for oral consultation
between the pharmacy and the patient,
under certain circumstances, to a nonresident pharmacy as are applicable to a pharmacy that has been issued a permit by the
Board. [S. Appr]
SB 1153 (Watson). Existing law provides for the Medi-Cal program administered by DHS, pursuant to which medical
benefits, including certain prescription
drugs, are provided to public assistance
recipients and certain other low-income
persons. As amended April 28, this bill
would establish the Drug Utilization Review Board to review, evaluate, and make
recommendations to DHS on retrospective drug utilization reviews, standards applications, educational interventions, and
drug utilization program profile development. This bill would also require the
Board of Pharmacy, with the advice of the
Drug Utilization Review Board, to adopt
and publish guidelines and standards to be
used by pharmacists in their counseling of
Medi-Cal recipients. [S. Appr]
AB 2020 (Isenberg), as amended May
18, would, among other things, authorize
optometrists to use, prescribe, and dispense specified pharmaceutical compounds to a patient. This bill would also
make it a misdemeanor for any person
licensed as an optometrist to refer a patient
to a pharmacy that is owned by that licensee or in which the licensee has proprietary interest. [A. Floor]
SB 1136 (Kelley). Under the Medi-Cal
program administered by DHS, pharma-
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cists are reimbursed for covered drugs
based on prices determined by the Department; existing law authorizes pharmacists
to select a generic drug type, as defined,
over a name brand drug product when
filling a prescription, unless the prescriber
specifies otherwise. As amended May 5,
this bill would require that a generically
substitutable product shall not be reimbursable if the DHS Director determines
that a product from a company subject to
rebates as an innovator company under
federal law is lower in net cost to the state
than a generically substitutable product
not subject to the rebates; it would require
the Director to notify pharmacists of these
determinations. [S. Appr]

■ LITIGATION
Plaintiffs are appealing the trial court's
ruling in Californians for Safe Prescriptions v. California State Board of Pharmacy, No. BS019433 (Dec. 15, 1992),
which held that the Board followed and
complied with the Administrative Procedure Act in promulgating and adopting its
pharmacy technician regulations. [ 13:1
CRLR 62] Plaintiffs, members of a nonprofit organization consisting of approximately 5,000 licensed pharmacists, filed a
notice of appeal on January 5; at this writing, no date for oral argument has been set.
On February 18, the California Supreme Court granted the pharmacy's petition for review of the Fifth District Court
of Appeal's decision in Huggins v. Longs
Drug Stores California, Inc., No.
F016033 (Dec. 4, 1992). The appellate
court held that a pharmacist's provision of
incorrect dosage amounts for a prescription which the pharmacist knew or should
have known would be administered to an
infant by the infant's parents constitutes
negligent action directed at the parent caregivers, which may allow the caregivers
to recover damages for negligent infliction of emotional distress. [13: 1 CRLR

63]

■ RECENT MEETINGS
At the Board's January 20-21 meeting,
the Board considered its Long-Term Care
Committee's recommendation that it adopt
proposed standards for pharmacies servicing long-term care facilities. Among other
things, the standards state the obligations of
pharmacies servicing such facilities, which
include establishing procedures for obtaining and providing necessary drugs on a
timely manner, including on a 24-hour basis,
and for the availability of emergency drug
supplies, in conformity with federal and
state laws and regulations, and maintaining
drug information services available to facility nursing staff, prescribers, other physi-

cians, and the facility's consultant pharmacist. Following discussion, the Board
unanimously adopted the standards.

■ FUTURE MEETINGS
October 6-7 in Sacramento.

BOARD OF
REGISTRATION FOR
PROFESSIONAL
ENGINEERS AND
LAND SURVEYORS
Executive Officer:
Harold L. Turner
(916) 263-2222
he Board of Registration for Professional Engineers and Land Surveyors
(PELS) regulates the practice of engineering and land surveying through its administration of the Professional Engineers
Act, sections 6700 through 6799 of the
Business and Professions Code, and the
Professional Land Surveyors' Act, sections 8700 through 8805 of the Business
and Professions Code. The Board's regulations are found in Division 5, Title 16 of
the California Code of Regulations
(CCR).
The basic functions of the Board are to
conduct examinations, issue certificates,
registrations, and/or licenses, and appropriately channel complaints against registrants/licensees. The Board is additionally
empowered to suspend or revoke registrations/licenses. The Board considers the
proposed decisions of administrative law
judges who hear appeals of applicants
who are denied a registration/license, and
those who have had their registration/license suspended or revoked for violations.
The Board consists of thirteen members: seven public members, one licensed
land surveyor, four registered Practice Act
engineers and one Title Act engineer.
Eleven of the members are appointed by
the Governor for four-year terms which
expire on a staggered basis. One public
member is appointed by the Speaker of the
Assembly and one by the Senate Rules
Committee.
The Board has established four standing committees and appoints other special
committees as needed. The four standing
committees are Administration, Enforcement, Examination/Qualifications, and
Legislation. The committees function in
an advisory capacity unless specifically
authorized to make binding decisions by
the Board.

T

California Regulatory Law Reporter• Vol.13, Nos. 2&3 (Spring/Summer 1993)

Professional engineers are registered
through the three Practice Act categories
of civil, electrical, and mechanical engineering under section 6730 of the Business and Professions Code. The Title Act
categories of agricultural, chemical, control system, corrosion, fire protection, industrial, manufacturing, metallurgical,
nuclear, petroleum, quality, safety, and
traffic engineering are registered under
section 6732 of the Business and Professions Code.
Structural engineering and geotechnical engineering are authorities linked to
the civil Practice Act and require an additional examination after qualification as a
civil engineer.
At its January 29 meeting, PELS selected Harold L. Turner as its new Executive Officer; Turner, formerly California's
Deputy Auditor General, was hired to replace Darlene Stroup, who resigned in
August 1992. [13:1 CRLR 64] In February, Governor Wilson announced the appointment of Stephen H. Lazarian as
PELS' new public member; Lazarian is a
self-employed attorney from Pasadena
who formerly served on the Contractors
State License Board from 1985-92 and
was its chair from 1988-89.

■ MAJOR PROJECTS
Proposed Elimination of Title Act
Protection for Traffic Engineers. At its
March 12 meeting, PELS discussed the
possible elimination of Title Act coverage
for traffic engineering. The proposed action is opposed by S.E. Rowe, General
Manager of the City of Los Angeles' Department of Transportation, who contends
that title protection for traffic engineering
is necessary primarily because of its "extreme implications in saving lives and reducing injuries and property damage to
the public." If protection is eliminated,
Rowe contends that a registered civil engineer with little or no experience in traffic
engineering could make traffic recommendations on behalf of his/her clients.
Department of Consumer Affairs (DCA)
legal counsel Don Chang noted that preparation of certain traffic mitigation or
worksite traffic control plans does not
constitute the practice of civil engineering. Board President Larry Dolson referred the matter to a special committee to
further consider the scope of Title Act
coverage.
At PELS' April 23 meeting, Board
member Ted Fairfield reported that, based
on a review of current National Council of
Examiners for Engineering and Surveying
(NCEES) test questions and most college
curricula, there appear to be inconsistencies between the definition and educa-
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